Cancer Patients Europe Annual Activity Report 2024
Cancer Patients Europe’s Annual Activity Report 2024 documents a year of significant expansion and strategic advocacy. CPE grew to 56 members across 26 countries and increased staff to 7 members. Key achievements include shaping patient engagement under the EU HTA Regulation through webinars and consultations, contributing to the European Health Data Space regulation as part of a 39-organisation coalition, and launching the joint Manifesto on a European Semester on Health with CECOG. The report covers the European Week Against Cancer webinar series culminating in a Call to Action on reducing cancer care inequalities, the ESR1 mutations and liquid biopsy awareness campaign for metastatic breast cancer, dedicated work on rare cancers including BPDCN and pancreatic cancer, and CPE’s role in 9 EU-funded research projects (QUALITOP, PREVENT, INTERCEPTOR, THERMOBREAST, GLIOMATCH, IMAGIO, OncoProTools, INTERVENE, EOSC4Cancer). The report includes governance updates, financial overview, and acknowledgements to partners and stakeholders.